Supply of genetically modified autologous immunocellular therapy named Kymriah, exclusive of the Novartis Pharmaceutical S.A.U. company for Hospital General Universitario Gregorio Marañón
Awarded
- Supplies
- España
- A-SUM-024545-2023
Amount
€2,764,800.00
Tender for Supply of genetically modified autologous immunocellular therapy named Kymriah, exclusive of the Novartis Pharmaceutical S.A.U. company
The tender identified with expedient A-SUM-024545-2023 is related to the sector Supplies.
This tender is located in España, Not specified, ES.
All information updated in real time
Hospital General Universitario Gregorio Marañón
Total tenders
867
Active tenders
15
Total awards
803
Related Organizations
265
Sources
Documents
CPVs
Location:
EspañaStatus
AwardedProcedure
UndefinedContract type
SuppliesPublication date
February 25, 2026Budget excluding taxes
€2,764,800.00Estimated contract value
€2,764,800.00Deadline
-Contract duration
-Extension
-Guarantee
-
View complete and updated information
To access all detailed and updated information about this tender, access our Tendios platform.
Access Tendios